Hospital

Nearly 18-times more patients on trizepatide 15 mg achieved a body weight reduction of 15% or more compared to placebo.

Key topics in May include mental illness for pharmacists, pharmacy technicians, and PharmD candidates.

The BCG vaccine was more likely to cause symptomatic or severe COVID-19 in patients that had a preexisting condition, such as heart disease, by 6 months.

Given the increasing value of patient satisfaction in determining the quality of care in the hospital reimbursement model, research is flourishing with a focus on identifying the factors that could positively influence patient satisfaction outcomes.

The flexible 1- and 2-month dosing intervals of risperidone could help address adherence challenges common with schizophrenia treatments.

Study shows intramuscular injection may improve treatment success by increasing the speed of drug absorption.

Investigators suggest that a checklist completed by physicians and family members of individuals with severe acute brain injury may improve management needs.

Analysis shows that the ratio of neutralizing antibody geometric mean titers in adolescents compared with young adults was 1.5 after vaccination with NVX-CoV2373.

The willingness of biology labs to evolve has been essential to the incredible rise of biologic drugs.

The formulation in 960 mg and 720 mg prefilled syringes delivers sustained plasma concentrations comparable to those demonstrated in studies with Abilify Maintena.

Proposed rules would permit a telehealth provider to prescribe only up to a 30-day supply of a Schedule III-V non-narcotic controlled substance or buprenorphine through telehealth without the patient first being evaluated in person by a provider.

Nearly 84% of hospitals are working to prevent and mitigate burnout, with increased support and programs for individual wellness and resilience practices.

Risk of incident diabetes was markedly higher among males and in those with more severe COVID-19.

Prevnar 20 is a next-generation pneumococcal conjugate vaccine that includes capsular polysaccharide conjugates for the 13 serotypes already included in Prevnar 13.

The APPOINT-PNH study showed that twice-daily LNP023 (Iptacopan) helped patients with paroxysmal nocturnal hemoglobinuria control intravascular hemolysis.

Through 8 weeks after treatment, C. difficile recurrence in SER-109-treated participants was lower compared to placebo-treated participants.

Less than 20% of physicians were open to starting a patient with nonvalvular atrial fibrillation on an anticoagulant after conducting a clinical review of the patient’s care.

Fecal microbiota transplantation may result in a slight reduction in serious adverse events, but the confidence intervals around the summary estimate were wide in immunocompetent adults with recurrent C. difficile infection.

The analysis, published in Nature Communications, demonstrates glycan trimming also keeps the antibody response away from immunodominant glucan holes and patches.

The median change from baseline at week 24 in the 6-minute walk distance was 34.4 m in the sotatercept group and 1 m in the placebo group among patients with pulmonary arterial hypertension.

Analysis focuses on couples in the greater New Haven area in Connecticut between October 2020 and August 2021.

The market for digital therapeutics products is expected to grow given increasing global access to smart technologies, their cost-effectiveness, and the need for patient-specific treatments.

Both barriers and facilitating factors, as well as a history of STIs, are associated with recent PrEP use among urban transgender women.

Pharmacists were asked about their levels of burnout, drivers and symptoms of this burnout, and what steps their workplaces had taken to improve the issue.

Cate Lockhart, PharmD, PhD, executive director of the Biologics and Biosimilars Collective Intelligence Consortium, discussed the growing biosimilars landscape .

Infants diagnosed with invasive Group B Streptococcus meningitis had an increased risk of developing epilepsy if the mother was of lower income.

Prediagnostic weight loss could be an important marker for colorectal cancer diagnosis.

The SUNRISE-3 trial is investigating its use in high-risk patients regardless of COVID-19 vaccination status.

While the demand for professionals adept in the ability to work with big data is at an all-time high, there remains a significant lack of skilled talent.

Study results indicate a decrease in the exclusion of older adults but no significant change for individuals who are immunocompromised.